Her er først lige hvad der er godkendt til behandlingen i dag:

Drugs Approved for Cervical Cancer

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for cervical cancer. The list includes generic names, brand names, and common drug combinations, which are shown in capital letters. The drug names link to NCI's Cancer Drug Information summaries.

(www.cancer.gov)

Nu har jeg hurtigt kigget igennem nogle få abstracts der blev præsenteret indenfor cervical cancer på ASCO 2017 - her er lige et par enkelte uddrag af antistoffer, da det vel er det vi kan sammenligne med i første omgang:

Pembrolizumab for previously treated advanced cervical squamous cell cancer: Preliminary results from the phase 2 KEYNOTE-158 study:Results: Among the first 47 patients with advanced cervical cancer who enrolled, ORR was 17% (95% CI, 8%-31%), with 3 confirmed and 5 unconfirmed responses. 41 (87%) patients had PD-L1-positive tumors, and ORR was independent of PD-L1 status. Among the 15 patients who had ≥27 weeks of follow-up, ORR was 27% (95% CI 8%-55%), with 3 confirmed responses and 1 unconfirmed response. Safety and updated efficacy data for 83 patients with ≥27 weeks of follow-up will be available for presentation.

http://abstracts.asco.org/199/AbstView_199_194350.html

An open-label, multicohort, phase I/II study of nivolumab in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in recurrent or metastatic (R/M) cervical, vaginal, and vulvar cancers: Results: Of 24 treated patients (pts), 19 had cervical and 5 had vaginal or vulvar cancer; median age was 51 y. At a median follow-up of 31 wks (range: 6-38), ORR was 20.8% (Table), and disease control rate (ORR + SD) was 70.8%. All responses were in pts with cervical cancer (ORR, 26.3%) and were observed regardless of PD-L1 or HPV status or number of prior R/M therapies. Median PFS was 5.5 mo (95% CI: 3.5, NR); median OS was NR

http://abstracts.asco.org/199/AbstView_199_184153.html

Her også lige godkendelsen af bevazizumab (Avastin):

(www.ucirvinehealth.org)

Det var blot en start - kom gerne med det i finder !

Mvh
Sukkeralf